The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
123319824 12331982 4 F 201603 20160706 20160504 20160711 EXP US-PFIZER INC-2016240344 PFIZER 73.00 YR F Y 70.00000 KG 20160711 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
123319824 12331982 1 PS TOVIAZ FESOTERODINE FUMARATE 1 Oral 4MG TABLETS AT NIGHT Y M25503 22030 4 MG MODIFIED-RELEASE TABLET
123319824 12331982 2 SS TOVIAZ FESOTERODINE FUMARATE 1 4 MG, 2X/DAY Y M25503 22030 4 MG MODIFIED-RELEASE TABLET BID
123319824 12331982 3 C METOPROLOL TARTRATE. METOPROLOL TARTRATE 1 50 MG ONE IN THE MORNING 0 50 MG QD
123319824 12331982 4 C AMLODIPINE BESILATE AMLODIPINE BESYLATE 1 2.5 MG TAKE ONE IN THE AFTERNOON 0 2.5 MG QD
123319824 12331982 5 C LOSARTAN POTASSIUM. LOSARTAN POTASSIUM 1 50 MG ONE AT NIGHT 0 50 MG QD
123319824 12331982 6 C ALLOPURINOL. ALLOPURINOL 1 300 MG EVERY NIGHT 0 300 MG QD
123319824 12331982 7 C NAPROXEN. NAPROXEN 1 500 MG, 2X/DAY (500MG IN MORNING AND AT NIGHT) 0 500 MG BID
123319824 12331982 8 C POTASSIUM CHLORIDE. POTASSIUM CHLORIDE 1 10 MEQ ONE AT NIGHT 0 10 MEQ QD
123319824 12331982 9 C CALCIUM CITRATE CALCIUM CITRATE 1 1 DF, DAILY 0 1 DF
123319824 12331982 10 C VITAMIN B12 CYANOCOBALAMIN 1 1000 UG ONE A DAY 0 1000 UG TABLET QD
123319824 12331982 11 C HYDROCODONE HYDROCODONE 1 5/325MG ONE 2 - 3 TIMES A DAY 0 1 DF
123319824 12331982 12 C LEVOTHYROXINE. LEVOTHYROXINE 1 50 UG TAKE ONE EVERY MORNING 0 50 UG QD
123319824 12331982 13 C DIPHENHYDRAMINE. DIPHENHYDRAMINE 1 1 DF, TAKE ONE EVERY MORNING 0 1 DF QD
123319824 12331982 14 C PRAVASTATIN. PRAVASTATIN 1 40 MG, 1X/DAY(AT NIGHT) 0 40 MG QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
123319824 12331982 1 Urinary incontinence
123319824 12331982 2 Bladder disorder
123319824 12331982 3 Blood pressure abnormal
123319824 12331982 4 Blood pressure abnormal
123319824 12331982 5 Blood pressure abnormal
123319824 12331982 6 Gout
123319824 12331982 7 Arthritis
123319824 12331982 8 Blood potassium
123319824 12331982 9 Bone disorder
123319824 12331982 10 Vitamin B12 decreased
123319824 12331982 11 Pain
123319824 12331982 12 Thyroid disorder
123319824 12331982 13 Hypersensitivity
123319824 12331982 14 Blood cholesterol

Outcome of event

Event ID CASEID OUTC COD
123319824 12331982 OT
123319824 12331982 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
123319824 12331982 Hallucination
123319824 12331982 Nightmare
123319824 12331982 Product use issue

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
123319824 12331982 1 201603 20160427 0
123319824 12331982 2 20160401 0
123319824 12331982 3 201012 0
123319824 12331982 4 201012 0
123319824 12331982 5 201012 0
123319824 12331982 6 201012 0
123319824 12331982 7 201012 0
123319824 12331982 8 201012 0
123319824 12331982 9 201012 0
123319824 12331982 10 201601 0
123319824 12331982 11 201512 0
123319824 12331982 12 201512 0
123319824 12331982 13 201412 0
123319824 12331982 14 201412 0